The consequences of advanced chronic kidney disease are severe. When these essential organs can no longer do their job of ...
Novo Nordisk said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial. The pill lowered the risk ...
Oral semaglutide reduced risk for major adverse CV events by 14% in high-risk adults with type 2 diabetes regardless of SGLT2 ...
Injectable semaglutide has better bioavailability, researchers say, but the many patients who want an oral drug are an unmet ...
Rybelsus® reduced major adverse cardiovascular events by 14% vs placebo in adults with type 2 diabetes and cardiovascular and ...
Weight fluctuation was associated with a greater risk for diabetic kidney disease progression among individuals with type 1 diabetes.
MONDAY, March 17, 2025 (HealthDay News) -- The global burden of diabetic nephropathy increased from 1990 to 2021, and is ...
Chronic kidney disease (CKD) has diverse etiologies and complex pathogenesis, and is prone to recurrent episodes and prolonged illness. In recent years, the prevalence of CKD has been increasing year ...
The following is a summary of “Lipid abnormality in diabetic kidney disease and potential treatment advancements,” published ...